Does Renal Mass Ablation Provide Adequate Long-term Oncologic Control?

Stephen Faddegon, Jeffrey A Cadeddu

Research output: Contribution to journalReview articlepeer-review

20 Scopus citations

Abstract

Renal ablation (RA) is no longer used exclusively in patients with limited life expectancy. There are few studies reporting a minimum follow-up of 5 years. Biases and discrepancies within the literature are abundant. The outcomes of any series must be interpreted in the context of median follow-up time, reported tumor characteristics, ablation technique and training background of the practitioner, and the definition of tumor recurrence. The long-term oncologic efficacy of radiofrequency ablation (RFA) and cryoablation appear similar, although the percutaneous RFA technique may necessitate reablation in more cases. RA is associated with slightly higher rates of local recurrence compared to surgical excision.

Original languageEnglish (US)
Pages (from-to)181-190
Number of pages10
JournalUrologic Clinics of North America
Volume39
Issue number2
DOIs
StatePublished - May 1 2012

Keywords

  • Cryoablation
  • Radiofrequency ablation
  • Renal neoplasm
  • Small renal mass

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'Does Renal Mass Ablation Provide Adequate Long-term Oncologic Control?'. Together they form a unique fingerprint.

Cite this